**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
**LINKEDIN CORP, $186.46, down 8 pct. **VIVUS INC, $13.28, up 3 pct. Arena said on Thursday that it pulled its application seeking approval for its anti-obesity treatment Belviq in the European Union, lowering competition for rival Vivus, whose obesity pill was recommended for European approval by regulators late last month.
May 3- Pitney Bowes Inc:. *Abby f. kohnstamm joins Pitney Bowes as chief Marketing officer. *Source text for Eikon* Further company coverage ().
**RADCOM LTD, $4.05, up 53 pct. **LINKEDIN CORP, $181.69, down 10 pct. The U.S. Justice Department is suing the company and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.
rose 0.17 percent and the Nasdaq Composite Index gained 0.58 percent. **APPLE INC, $442,5, up 3 pct. **TRANSITION THERAPEUTICS INC, $3.27, up 45 pct.
Wall Street opened flat on Tuesday as investors awaited economic data and central bank meetings this week, looking for catalysts to push the benchmark S&P 500 index through 1,600. The Dow Jones industrial average dropped 0.11 percent. **APPLE INC, $434, up 1 pct.
Staff reviewers for the U.S. Food and Drug Administration are expected to ask a panel of medical experts on May 2 if another clinical trial is required before it approves an experimental kidney cancer drug made by Aveo Oncology and Astellas Pharma Inc. **MGIC INVESTMENT CORP, Monday close $5.48, down 13 pct premarket.
**MGIC INVESTMENT CORP, Monday close $5.48, down 13 pct premarket. **PFIZER INC, Monday close $30.43, down 3 pct premarket. **ZOETIS INC, Monday close $32.66.
NEW YORK, April 30- Pitney Bowes Inc:.
March 25- Pitney Bowes Inc has won the dismissal of a securities fraud lawsuit accusing it of misleading investors by not disclosing problems in its businesses that in 2007 caused it to miss financial projections for the first time in seven years.